Improvement of Postreceptor Events by Metoprolol Treatment in Patients With Chronic Heart Failure

This publication has 30 references indexed in Scilit:

• Alterations of ?-adrenoceptor-G-protein-regulated adenylyl cyclase in heart failure
  Molecular and Cellular Biochemistry, 1995
• A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.
  Circulation, 1994
• Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy.
  Circulation, 1991
• Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium.
  Circulation Research, 1991
• Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy.
  Circulation, 1990
• Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.
  Circulation, 1989
• Mechanism of noradrenaline-induced heterologous desensitization of adenylate cyclase stimulation in rat heart muscle cells: increase in the level of inhibitory G-protein α-subunits
  European Journal of Pharmacology: Molecular Pharmacology, 1989
• INCREASE IN MYOCARDIAL Gi-PROTEINS IN HEART FAILURE
  The Lancet, 1988
• Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart.
  Journal of Clinical Investigation, 1988
• Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure.
  Circulation, 1987